# Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

> **NCT03593707** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Metformin
- **DRUG:** PF-06865571

## Key facts

- **NCT ID:** NCT03593707
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2019-01-17
- **Final completion:** 2019-02-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03593707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03593707, "Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03593707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*